✦ LIBER ✦

Detection of tumor mutant DNA in plasma of patient with colorectal cancer

✍ Scribed by Ming Li; Wen-hui Wan; Jin Gu

Publisher: Chinese Anti-Cancer Association
Year: 2002
Tongue: English
Weight: 263 KB
Volume: 14
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-002-0034-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of free-circulating tumor-asso

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis

✍ Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

## Abstract Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of free‐circulating tumor‐associated DNA. The objective of our study w

Detection of mitochondrial DNA alteratio

Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients

✍ Kenji Hibi; Hiroshi Nakayama; Taiji Yamazaki; Tsunenobu Takase; Masumi Taguchi; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 1 views

Detection of tumor-specific DNA in blood

Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer

✍ Heidi Schwarzenbach; Felix K.-H. Chun; Imke Lange; Sebastian Carpenter; Miriam G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 605 KB

## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCR‐based fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro

Detection of disseminated tumor cells in

Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients

✍ Marc G. Denis; Cecile Lipart; Joël LeBorgne; Paul-Antoine LeHur; Jean-Paul Galmi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB 👁 2 views

All cancer staging systems seek to identify clinical and pathological features that can predict outcome or guide therapy. In particular, a non-invasive method for the early detection of disseminating disease would be of great interest. We investigated the use of cytokeratin genes expression to detec

Detection of K-ras mutations in stools o

Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR

✍ Peter Nollau; Carsten Moser; Günter Weinland; Christoph Wagener 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

Mutant-enriched PCR was applied to the detection of mutations at codons I 2 and I 3 of K-ras genes in the stools of patients with colorectal cancer. Mutations were analyzed in stool samples obtained prior to surgery. Resected tumor specimens were screened for K-ras mutations by PCR-mediated RFLP ana

Detection of APC mutations in stool DNA

Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR

✍ Rainer Deuter; Oliver Müller 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

In most cases the analysis of DNA mutations in presence of a high excess of wild type DNA fail because of the low sensitivity of the performed method for mutation detection. Here we describe the new high-sensitive and non-radioactive HD-PCR method (for HeteroDuplex-PCR). In opposite to the conventio